CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-01-16 | Smith Robin L Exec. Chairman of the Board | Shares withheld for taxes | −20,117 | $3.48 | $70K | 309,293 |
| 2015-01-16 | Smith Robin L Exec. Chairman of the Board | Returned to the company · Stock Option (right to purchase) | −50,000 | 250,000 | ||
| 2015-01-15 | Pecora Andrew L Chief Visionary Officer | Grant or award | +684 | $3.82 | $3K | 348,780 |
| 2015-01-05 | VATERS ROBERT S President & CFO | Grant or award · Stock Option (right to purchase) | +480,000 | 480,000 | ||
| 2015-01-05 | VATERS ROBERT S President & CFO | Grant or award · Stock Option (right to purchase) | +120,000 | 120,000 | ||
| 2015-01-05 | Mazzo David J Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +620,000 | 620,000 | ||
| 2015-01-05 | Mazzo David J Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +200,000 | 200,000 | ||
| 2015-01-02 | Smith Robin L Exec. Chairman of the Board | Grant or award · Stock Option (right to purchase) | +300,000 | 300,000 | ||
| 2015-01-02 | Preti Robert A | Grant or award · Stock Option (right to purchase) | +50,000 | 50,000 | ||
| 2015-01-02 | VACZY CATHERINE M General Counsel | Grant or award · Stock Option (right to purchase) | +45,000 | 45,000 | ||
| 2015-01-02 | Talamo Joseph Chief Accounting Officer | Grant or award · Stock Option (right to purchase) | +30,000 | 30,000 | ||
| 2015-01-02 | LOSORDO DOUGLAS W Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2015-01-02 | Pecora Andrew L Chief Visionary Officer | Grant or award · Stock Option (right to purchase) | +75,000 | 75,000 | ||
| 2015-01-02 | Smith Robin L Chairman and CEO | Grant or award · Stock Option (right to purchase) | +150,000 | 150,000 | ||
| 2015-01-02 | GREENACRE MARTYN D Director | Grant or award | +14,000 | 78,531 | ||
| 2015-01-02 | BERNSTEIN DREW Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2015-01-02 | BERMAN RICHARD J Director | Grant or award | −18,000 | 18,000 | ||
| 2015-01-02 | MYERS STEVEN S Director | Grant or award | +19,000 | 142,931 | ||
| 2015-01-02 | KLOSK STEVEN M Director | Grant or award | +12,000 | 22,000 | ||
| 2015-01-02 | RimAsia Capital Partners Manager, Ltd. Director | Gift | +12,000 | 2,222,988 |
Page 20 of 24 · 477 trades